Fluvastatin Suppresses Native and Recombinant Human P2X4 Receptor Function

Overview

Journal Purinergic Signal

Publisher Springer

Date 2012 Jan 7

PMID 22222818

Citations 12

Authors

Jing Li

Samuel J Fountain

Affiliations

Soon will be listed here.

Abstract

Statins have both cholesterol lowering and anti-inflammatory activities, whether mechanisms underlying their activities are independent remains unclear. The ATP-gated P2X(4) receptor is a pro-inflammatory mediator. Here, we investigate the action of fluvastatin and other cholesterol depleting agents on native and recombinant human P2X(4) receptor. Fluvastatin and mβCD suppressed P2X(4)-dependent calcium influx in THP-1 monocytes, without affecting P2Y receptor responses. mβCD or filipin III suppressed the current density of recombinant human P2X(4) receptors. Human P2X(2) was insensitive to cholesterol depletion. Cholesterol depletion had no effect on intrinsic P2X(4) receptor properties as judged by ATP concentration-response relationship, receptor rundown or current decay during agonist occupancy. These data suggest fluvastatin suppresses P2X(4) activity in monocytes through cholesterol depletion and not by modulating intrinsic channel properties.

Citing Articles

Activation of the plant mevalonate pathway by extracellular ATP.

Cho S, Toth K, Kim D, Vo P, Lin C, Handakumbura P Nat Commun. 2022; 13(1):450.

PMID: 35064110 PMC: 8783019. DOI: 10.1038/s41467-022-28150-w.

Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases.

Braganca B, Correia-de-Sa P Int J Mol Sci. 2020; 21(14).

PMID: 32679900 PMC: 7404342. DOI: 10.3390/ijms21145005.

ATP-Evoked Intracellular Ca Responses in M-CSF Differentiated Human Monocyte-Derived Macrophage are Mediated by P2X4 and P2Y11 Receptor Activation.

Layhadi J, Fountain S Int J Mol Sci. 2019; 20(20).

PMID: 31618941 PMC: 6834299. DOI: 10.3390/ijms20205113.

ATP Evokes Ca Responses and CXCL5 Secretion via P2X Receptor Activation in Human Monocyte-Derived Macrophages.

Layhadi J, Turner J, Crossman D, Fountain S J Immunol. 2017; 200(3):1159-1168.

PMID: 29255078 PMC: 5784824. DOI: 10.4049/jimmunol.1700965.

P2X4 Receptor-Dependent Ca Influx in Model Human Monocytes and Macrophages.

Layhadi J, Fountain S Int J Mol Sci. 2017; 18(11).

PMID: 29077063 PMC: 5713231. DOI: 10.3390/ijms18112261.

References

Priel A, Silberberg S . Mechanism of ivermectin facilitation of human P2X4 receptor channels. J Gen Physiol. 2004; 123(3):281-93. PMC: 2217454. DOI: 10.1085/jgp.200308986. View

Tsuda M, Shigemoto-Mogami Y, Koizumi S, Mizokoshi A, Kohsaka S, Salter M . P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003; 424(6950):778-83. DOI: 10.1038/nature01786. View

Wareham K, Vial C, Wykes R, Bradding P, Seward E . Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol. 2009; 157(7):1215-24. PMC: 2743840. DOI: 10.1111/j.1476-5381.2009.00287.x. View

Sim J, Park C, Oh S, Evans R, North R . P2X1 and P2X4 receptor currents in mouse macrophages. Br J Pharmacol. 2007; 152(8):1283-90. PMC: 2034508. DOI: 10.1038/sj.bjp.0707504. View

. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994; 344(8934):1383-9. View

Scalia R, Gooszen M, Jones S, Hoffmeyer M, Rimmer 3rd D, Trocha S . Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation. 2001; 103(21):2598-603. DOI: 10.1161/01.cir.103.21.2598. View

Ulmann L, Hirbec H, Rassendren F . P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J. 2010; 29(14):2290-300. PMC: 2910276. DOI: 10.1038/emboj.2010.126. View

Allsopp R, Lalo U, Evans R . Lipid raft association and cholesterol sensitivity of P2X1-4 receptors for ATP: chimeras and point mutants identify intracellular amino-terminal residues involved in lipid regulation of P2X1 receptors. J Biol Chem. 2010; 285(43):32770-32777. PMC: 2963349. DOI: 10.1074/jbc.M110.148940. View

Fountain S, North R . A C-terminal lysine that controls human P2X4 receptor desensitization. J Biol Chem. 2006; 281(22):15044-9. DOI: 10.1074/jbc.M600442200. View

10.

Qureshi O, Paramasivam A, Yu J, Murrell-Lagnado R . Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis. J Cell Sci. 2007; 120(Pt 21):3838-49. DOI: 10.1242/jcs.010348. View

11.

Liu M, Huang W, Wu D, Priestley J . TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors. Eur J Neurosci. 2006; 24(1):1-6. DOI: 10.1111/j.1460-9568.2006.04889.x. View

12.

Vial C, Evans R . Disruption of lipid rafts inhibits P2X1 receptor-mediated currents and arterial vasoconstriction. J Biol Chem. 2005; 280(35):30705-11. PMC: 1435685. DOI: 10.1074/jbc.M504256200. View

13.

Wang L, Jacobsen S, Bengtsson A, Erlinge D . P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol. 2004; 5:16. PMC: 509419. DOI: 10.1186/1471-2172-5-16. View

14.

Barth K, Weinhold K, Guenther A, Linge A, Gereke M, Kasper M . Characterization of the molecular interaction between caveolin-1 and the P2X receptors 4 and 7 in E10 mouse lung alveolar epithelial cells. Int J Biochem Cell Biol. 2008; 40(10):2230-9. DOI: 10.1016/j.biocel.2008.03.001. View

15.

North R . Molecular physiology of P2X receptors. Physiol Rev. 2002; 82(4):1013-67. DOI: 10.1152/physrev.00015.2002. View

16.

Pruefer D, Makowski J, Schnell M, Buerke U, Dahm M, Oelert H . Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation. 2002; 106(16):2104-10. DOI: 10.1161/01.cir.0000034048.38910.91. View

17.

Osterud B, Bjorklid E . Role of monocytes in atherogenesis. Physiol Rev. 2003; 83(4):1069-112. DOI: 10.1152/physrev.00005.2003. View

18.

Hillyard D, Jardine A, McDonald K, Cameron A . Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes. Atherosclerosis. 2004; 172(2):219-28. DOI: 10.1016/j.atherosclerosis.2003.11.004. View

19.

Jones C, Chessell I, Simon J, Barnard E, Miller K, Michel A . Functional characterization of the P2X(4) receptor orthologues. Br J Pharmacol. 2000; 129(2):388-94. PMC: 1571843. DOI: 10.1038/sj.bjp.0703059. View